Abstract
Background: Cardiac troponins currently represent the preferred biomarkers for the detection of myocardial necrosis. The objective of the present study was to compare the performance of the Access® AccuTnI® assay (Beckman Coulter) measured on two different platforms, the UniCel® DxI 800 and the Access® 2 (Beckman Coulter). In particular, the serum cardiac troponin I (cTnI) concentration corresponding to 10% coefficient of variation (CV), the cTnI assay minimum detectable concentration (MDC), and the serum cTnI 99th percentile in healthy subjects were calculated.
Methods: The Access® AccuTnI® is a paramagnetic particle chemiluminescent immunoassay. Imprecision profiles were determined according to the Clinical and Laboratory Standards Institute EP5-A protocol using serum pools. The MDC was calculated as mean+3 SD of 20 determinations of the zero calibrator during one run. The 99th percentile was determined analyzing serum samples from 679 healthy blood donors (523 males, 156 females; 18–71 years old).
Results: cTnI concentrations are given in μg/L. 10% CV values (95% confidence interval, CI) were 0.0577 (0.0467–0.0750) (UniCel® DxI 800) and 0.0486 (0.0255–0.0596) (Access® 2). MDC values were 0.011 (UniCel® DxI 800) and 0.012 (Access® 2). The 99th percentile (95% CI) value was 0.0340 (0.0298–0.0410).
Conclusions: Our data confirm the reliability of the evaluated cTnI assay and demonstrate the comparability of the cTnI values between the platforms studied.
Clin Chem Lab Med 2009;47:367–71.
©2009 by Walter de Gruyter Berlin New York
